Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Uri Tal-Tene

CTech 24/7

  • “I expect miracles”: Gross hails Safe Superintelligence’s future as he joins Meta
  • IBM-backed Qedma raises $26M Series A to fight quantum computing errors
  • “We we know what to do”: Ilya Sutskever takes helm as CEO, rules out sale of Safe Superintelligence
  • Full list of Israeli high-tech funding rounds in 2025
More stories in CTech

Uri Tal-Tene

1 stories about Uri Tal-Tene
  • Coronavirus. Photo: Tal Shahar

    Enlivex Leveraged Coronavirus to Get Money out of Shareholders

    26.02.20|Uri Tal-Tene The company announced on Monday a plan to increase the manufacturing capacity for its experimental drug “in preparation for potential requests for treatment of coronavirus patients” and used the resulting stock boost to raise a direct offering of $8 million

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive